SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford GlycoSciences Plc

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (319)1/23/2003 4:53:47 AM
From: nigel bates  Read Replies (2) of 469
 
From CAT annual report (can't get it to format, so I have cut some stuff out...) -

On 15 November 2002 the Company had been notified, in accordance with Section 198 to 208 of the Companies Act 1985, of the following interests in the ordinary share capital of the Company:
Percentage of issued share Capital; Number of shares (15.11.2002)
FMR Corp., Fidelity International Ltd and Edward Johnson(i) 4,378,789; 12.09
Human Genome Sciences Inc. 1,670,000; 4.61
Oracle Partners L.P.(i) 1,246,445; 3.44
Capital Group Inc(i) 1,089,995; 3.01
Legal & General Investment Management 1,102,025; 3.04 –
(i) Includes interests of associated funds or funds managed.

US shareholdings
The Directors estimate that approximately 28.6% of shares are held by US shareholders.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext